February 22, 2025: FDA Adds Severe Pancreatitis, Kidney Injuries, and Death to Risks on Ozempics Label In the wake of startling reports about Ozempics complications, the FDA published an updated label for this injectable diabetes drug that doubles as a weight loss tool
A., Horbinski, C
If you suffered from serious health problems after taking a GLP-1 drug, our lawyers in Miami can help you file a GLP-1 lawsuit
Ozempic may help people with type 2 diabetes lose weight, and it may also help those without the disease, but there may be disadvantages that need to be carefully examined
In August 2024, Novo Nordisk, one of the pharmaceutical leaders in diabetes and obesity care, launched its weight-loss drug Wegovy in Australia, intended for chronic weight management in patients with obesity or overweight with related conditions like diabetes or hypertension, Wegovy entered the market amid ongoing Ozempic supply concerns